Clinical trial
A Clinical Pharmacology Study of Multiple Doses of TA-7284 in Patients With Type 2 Diabetes Mellitus
NCT00707954 is registered in ClinicalTrials.gov with Tanabe Pharma Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Clinical Pharmacology Study of Multiple Doses of TA-7284 in Patients With Type 2 Diabetes Mellitus
- Lead sponsor
- Tanabe Pharma Corporation
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- June 30, 2008
- Completion date
- February 28, 2009
- Enrollment
- 61 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
type 2 diabetes mellitus